Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Urogynecology Journal
Erschienen in: International Urogynecology Journal 5/2010

01.05.2010 | Original Article

Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse

verfasst von: Sushma Srikrishna, Dudley Robinson, Linda Cardozo

Erschienen in: International Urogynecology Journal | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Currently, there is no global outcome assessment index in prolapse research. Patient Global Impression of Improvement (PGI-I) has only been validated in incontinence. Our aim was to validate its use following prolapse surgery.

Methods

Women with prolapse were recruited from waiting lists and assessed objectively (pelvic organ prolapse quantification system (POP-Q)). Quality of life (QoL) was assessed with prolapse QoL questionnaire (pQoL). Patient goal achievement (visual analogue scale (VAS)) determined subjective satisfaction and PGI-I indicated overall satisfaction. We established construct validity of PGI-I by correlating final PGI-I response with other measures of response, measured at 1 year: (POP-Q/pQoL/VAS)

Results

There was excellent test—retest reliability and correlation between PGI-I and other outcome measures.

Conclusion

We believe this is the first study validating PGI-I as a global index of response to prolapse surgery. This may be a valuable addition not only in clinical practice but also in trials comparing surgical interventions.
Literatur
1.
Swift SE (2000) The distribution of pelvic organ support in a population of female subjects seen for routine gynaecological health care. Am J Obstet Gynecol 183:277–285CrossRefPubMed
2.
Swift SE, Woodman P, O'Boyle A et al (2005) Pelvic Organ Support Study (POSST): the distribution, clinical definition and epidemiology of pelvic organ support defects. Am J Obstet Gynecol 192:795–806CrossRefPubMed
3.
Slieker-ten HMCP, Vierhout M, Bloembergen H, Schoenmaker G (2004) Distribution of pelvic organ prolapse in a general population: prevalence, severity, aetiology and relation with function of pelvic floor muscles. Abstract presented at the Joint Meeting of ICS and IUGA, 25–27 August 2004, Paris, France
4.
Olsen AL, Smith VJ, Berstrom VO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed
5.
Black N, Griffiths J, Pope C, Bowling A, Abel P (1997) Impact of surgery for stress incontinence on morbidity: cohort study. BMJ 315:1493–1498PubMed
6.
Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185:1388–1395CrossRefPubMed
7.
Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C (2001) A new instrument to measure sexual function in women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 184:552–558CrossRefPubMed
8.
Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189(1):98–101CrossRefPubMed
9.
Feinstein AR (1987) Global indexes and scales. Clinimatrics. Yale University Press, New Haven (CT), pp 267–316
10.
Gill TM, Feinstein AR (1994) A critical appraisal of the quality of life measurements. JAMA 272:6619–6626CrossRef
11.
Bump RC, Mattiasson A, Bo K et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17CrossRefPubMed
12.
Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QoL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J 16:176–181CrossRef
13.
Guy W (1976) ECDEU assessment manual for psychopharmacology. Rockville (MD): National Institute of Mental health, US department of Health, Education and Welfare, p 217–222
14.
Oberg M, Wanstrom G, Hjertman H, Lunner T, Andersson G (2009) Development and initial validation of the 'Clinical Global Impression' to measure outcomes for audiological rehabilitation. Disabil Rehabil 19:1–9, Epub ahead of print
15.
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M (2009) Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 25:1677–1687CrossRefPubMed
16.
Jelovsek JE, Barber MD (2006) Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 294(5):1455–1461CrossRef
17.
Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar VM (2005) The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG 112(7):971–976CrossRefPubMed
18.
Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH (2004) How much is enough and who says so? Br J Obstet Gynaecol 111:605–612
19.
Srikrishna S, Robinson D, Cardozo L (2008) Is there a difference in patient and physician Quality Of Life evaluation in pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct 19(4):517–520CrossRefPubMed
20.
Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient centred goals for pelvic floor dysfunction surgery: what is success and is it achieved? Am J Obstet Gynaecol; 187:88–92CrossRef
21.
Hullfish KL, Bovbjerg VE, Steers WD (2004) Patient centred goals for pelvic floor dysfunction surgery: long-term follow up. Am J Obstet Gynaecol 191:201–205CrossRef
22.
Crosby RD, Kolotkin RL, Rhys Williams G (2003) Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 56:395CrossRefPubMed
Metadaten
Titel
Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse
verfasst von
Sushma Srikrishna
Dudley Robinson
Linda Cardozo
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 5/2010
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-009-1069-5

Weitere Artikel der Ausgabe 5/2010

International Urogynecology Journal 5/2010 Zur Ausgabe

Case Report

Sonohysterography in evaluation of Youssef’s syndrome

Case Report

Objective cure of urinary retention following laparoscopic hysterectomy for a large uterine fibroid

Original Article

Novel rat model of stress urinary incontinence with a retroflexed bladder

Original Article

MR features of the levator ani muscle in the immediate postpartum following cesarean delivery

Original Article

Can stronger pelvic muscle floor improve sexual function?

Case Report

Pudendal nerve neuromodulation with neurophysiology guidance: a potential treatment option for refractory chronic pelvi-perineal pain

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise